SCOTTSDALE, Ariz., May 25, 2007 (PRIME NEWSWIRE) -- TASER International, Inc. (Nasdaq:TASR) a market leader in advanced electronic control devices today announced that Dr. Jeffrey Ho presented a paper entitled the "State of Current Human Research and Electronic Control Devices (ECDs)" at the European Working Group Fourth European Symposium on Non-Lethal Weapons on May 23, 2007 in Ettlingen, Germany. The study addressed the most pertinent human research and the implications of recent research on the phenomenon of in custody deaths in law enforcement.
Jeff Ho, M.D., stated, "There appears to be increasing interest in (Electronic Control Device) ECD use in society from law enforcement, military and personal defense perspectives. Along with increasing use of these devices, there is also a heightened awareness of perceived association with (Sudden Death) SD events. This perception may be stimulated by media inaccuracy and sensationalism at times. It may also be the product of misapplied logic."
"There have been numerous human studies investigating the possible association between ECD application and SD events. To date, no clear association has been demonstrated when examining the currently recognized etiologies of sudden death such as cardiogenic, pulmonary, metabolic or thermoregulatory causes. Additionally, data exists to show that ECD use has the potential to save human lives within certain populations. We believe that further study of ECDs is recommended to validate our findings."
"This was a tremendous opportunity for Dr. Ho to present peer reviewed medical research to representatives from 14 countries around the world concerning the medical effects of TASER technology," said Rick Smith, CEO and Co-Founder of TASER International. "This research validates the general safety of TASER(r) technology. Dr. Ho is one of the leading authorities on TASER technology and was accepted to present in front of the prestigious group of less-lethal experts from their respective countries."
You may read the paper at: www.TASER.com/StateofECDs
About TASER International, Inc.
TASER International provides advanced electronic control devices for use in the law enforcement, military, private security and personal defense markets. TASER(r) devices use proprietary technology to incapacitate dangerous, combative or high-risk subjects who pose a risk to law enforcement officers, innocent citizens or themselves in a manner that is generally recognized as a safer alternative to other uses of force. TASER technology saves lives every day, and the use of TASER devices dramatically reduces injury rates for police officers and suspects. For more information on TASER life-saving technology, please call TASER International at (800) 978-2737 or visit our website at www.TASER.com.
Note to Investors
This press release contains forward-looking information within the meaning of Section 27A of the Securities Act of the 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the safe harbor created by those sections. The forward-looking information is based upon current information and expectations regarding TASER International. These estimates and statements speak only as of the date on which they are made, are not guarantees of future performance, and involve certain risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results could materially differ from what is expressed, implied, or forecasted in such forward-looking statements.
TASER International assumes no obligation to update the information contained in this press release. TASER International's forward looking statements in this press release and future results may be impacted by the completion of the restatement of the Company's financial results for the first quarter of 2005 and the second quarter of 2005, risks associated with rapid technological change, new product introductions, new technological developments and implementations, execution issues associated with new technology, ramping manufacturing production to meet demand, litigation results from Company filed lawsuits and other litigation including lawsuits resulting from alleged product related injuries, media publicity concerning allegations of deaths occurring after use of the TASER device and the negative impact this could have on sales, product quality, implementation of manufacturing automation, potential fluctuations in quarterly operating results, adjustments to these amounts which may be reflected in our 10Q filing, competition, financial and budgetary constraints of prospects and customers, international order delays, dependence upon sole and limited source suppliers, negative reports concerning TASER device uses, governmental inquiries and investigations, medical and safety studies, fluctuations in component pricing, government regulations, variation among law enforcement agencies with their TASER product experience, TASER device tests and reports, dependence upon key employees, and our ability to retain employees. TASER International's future results may also be impacted by other risk factors listed from time to time in its SEC filings, including, but not limited to, the Company's Form 10-QSBs and its Annual Report on Form 10-KSB.
The statements made herein are independent statements of TASER International. The inclusion of any third parties does not represent an endorsement of any TASER International products or services by any such third parties.